A multicentric retrospective study of pembrolizumab alone or with chemotherapy as a first-line in patients with metastatic non-small cell lung cancer
Latest Information Update: 02 Aug 2022
At a glance
- Drugs Pembrolizumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 07 Jun 2022 Results presented at the 58th Annual Meeting of the American Society of Clinical Oncology
- 20 Nov 2021 New trial record
- 21 Sep 2021 Results presented at the 46th European Society for Medical Oncology Congress.